Your browser doesn't support javascript.
loading
Etirinotecan pegol (NKTR-102) versus treatment of physician's choice in women with advanced breast cancer previously treated with an anthracycline, a taxane, and capecitabine (BEACON): a randomised, open-label, multicentre, phase 3 trial.
Perez, Edith A; Awada, Ahmad; O'Shaughnessy, Joyce; Rugo, Hope S; Twelves, Chris; Im, Seock-Ah; Gómez-Pardo, Patricia; Schwartzberg, Lee S; Diéras, Veronique; Yardley, Denise A; Potter, David A; Mailliez, Audrey; Moreno-Aspitia, Alvaro; Ahn, Jin-Seok; Zhao, Carol; Hoch, Ute; Tagliaferri, Mary; Hannah, Alison L; Cortes, Javier.
Afiliação
  • Perez EA; Mayo Clinic, Jacksonville, FL, USA. Electronic address: perez.edith@mayo.edu.
  • Awada A; Medical Oncology Clinic, Jules Bordet Institute, Brussels, Belgium.
  • O'Shaughnessy J; Baylor-Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA.
  • Rugo HS; University of California, San Francisco, CA, USA.
  • Twelves C; University of Leeds and St James's University Hospital, Leeds, UK.
  • Im SA; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
  • Gómez-Pardo P; Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Schwartzberg LS; The West Clinic, Memphis, TN, USA.
  • Diéras V; Institut Curie, Paris, France.
  • Yardley DA; Sarah Cannon Research Institute, Nashville, TN, USA.
  • Potter DA; University of Minnesota Department of Medicine and Masonic Cancer Center, Minneapolis, MN, USA.
  • Mailliez A; Centre Oscar Lambret, Lille, France.
  • Moreno-Aspitia A; Mayo Clinic, Jacksonville, FL, USA.
  • Ahn JS; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Zhao C; Nektar Therapeutics, San Francisco, CA, USA.
  • Hoch U; Nektar Therapeutics, San Francisco, CA, USA.
  • Tagliaferri M; Nektar Therapeutics, San Francisco, CA, USA.
  • Hannah AL; Sebastopol, CA, USA.
  • Cortes J; Vall d'Hebron Institute of Oncology, Barcelona, Spain; Ramon y Cajal University Hospital, Madrid, Spain.
Lancet Oncol ; 16(15): 1556-1568, 2015 Nov.
Article em En | MEDLINE | ID: mdl-26482278

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Neoplasias da Mama / Compostos Heterocíclicos de 4 ou mais Anéis / Antineoplásicos Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Neoplasias da Mama / Compostos Heterocíclicos de 4 ou mais Anéis / Antineoplásicos Idioma: En Ano de publicação: 2015 Tipo de documento: Article